Additionally, functionality was restored to the quadriceps muscle tissue
384 , e070856 (2024)
furthermore, the risk increases with longer treatment durations, higher doses, and when these agents are used for weight loss
GLP-1s show promise for metabolic and mental health In questioning how GLP-1 therapies may alter mood, this study not only provided preclinical causal evidence but also a potential therapeutic target
2008) indicate that PUF-3 and PUF-11 likely interact physically with LST-1 and SYGL-1
Body Mass Index (BMI): You have a documented body mass index (BMI) of 30 kg/m2 or higher, or your initial BMI is 27 kg/m2 or higher with at least one weight-related comorbid condition, such as a documented medical history of high blood pressure, high cholesterol, type 2 diabetes mellitus, or obstructive sleep apnea